These targeted therapies are being used to prevent cancer and treat patients more specifically according to the type of cancer they have.
Novel therapeutics have been created to block receptor activation that leads to improved patients' outcomes.
Neurostimulation, such as deep brain stimulation (DBS)
This noninvasive imaging technology is used in the treatment and diagnosis of eye diseases, such as diabetic retinopathy and macular holes.
BT involves the controlled application of heat in the lungs to improve pulmonary function and reduce asthma symptoms. This therapy is used to ward off asthma attacks.
This drug therapy inhibits uncontrolled blood vessel formation in the eye, which is the primary cause of age-related macular degeneration, and the leading cause of new blindness in older Americans.
This is a minimally invasive repair technique traditionally used in cardiology and now being used to treat vascular disease, including thoracic abdominal aneurysms.
This involves using second generation, small molecule tyrosine kinase inhibitors to block or modulate disease and provide treatments for advanced cancers, such as renal cell carcinoma.
This is the first implanted ventricular assist device that senses when to increase or decrease the rate of blood flow.
This emerging drug delivery method is being used to administer medication directly to the site where it is needed, without exposing the rest of the body to a drug's effects.